Use of inotropes and vasopressor agents in critically ill patients.
about
Expert consensus document: Echocardiography and lung ultrasonography for the assessment and management of acute heart failurePathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity.Vasopressors in obstetric anesthesia: A current perspectiveBreast necrosis secondary to vasopressor extravasation: management using indocyanine green angiography and omental flap closure.Enzymatic changes in myosin regulatory proteins may explain vasoplegia in terminally ill patients with sepsis.Dopexamine can attenuate the inflammatory response and protect against organ injury in the absence of significant effects on hemodynamics or regional microvascular flowDrug utilization pattern in critical care unit in a tertiary care teaching hospital in India.Inotropes and vasopressors: more than haemodynamics!Pharmacotherapy update on the use of vasopressors and inotropes in the intensive care unit.Safety considerations of septic shock treatment.Inflammation and cardiac dysfunction during sepsis, muscular dystrophy, and myocarditis.Midodrine for the weaning of vasopressor infusions.Vasopressors in shock: too early to move away from catecholamines?Effects of dobutamine, dopamine, phenylephrine and noradrenaline on systemic haemodynamics and intestinal perfusion in isoflurane anaesthetised horses.
P2860
Q29994549-C619CB5E-DEA9-43BC-82F4-C7A642EB817BQ34396286-2E06459C-310D-4C6B-8ECD-48CC9778BEECQ34967115-C469349E-5FD9-461C-A674-A6B65C18B125Q35552786-2291D727-D87C-4F5D-BC6A-1FB947F9E309Q36647003-ADCD3997-030D-4D4A-A5E6-D82B4D93EA9DQ36902534-55B4D32C-0FB9-44ED-B7D5-A42F48D9A261Q37476327-C27EE665-65B7-45E1-B350-4D9606F85F70Q37954703-B5A4C363-5E09-4CF0-8FAB-13E1F00F3EF0Q38272554-94400CC3-58D2-4674-BF36-7D884C5DB557Q38658651-9E9B7042-10A7-4C15-9FFA-C0D862D5E48BQ38940783-F99DC01F-9ECA-489A-8BD6-E0D99A3DAD0AQ39946093-9F825DBB-6272-4832-88DD-877085C68F71Q42265461-FBA2C7AA-BF19-45EA-8F36-82837B71560AQ47273216-8B32060D-F6BB-45BB-8F70-248F93144BF9
P2860
Use of inotropes and vasopressor agents in critically ill patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Use of inotropes and vasopressor agents in critically ill patients.
@ast
Use of inotropes and vasopressor agents in critically ill patients.
@en
type
label
Use of inotropes and vasopressor agents in critically ill patients.
@ast
Use of inotropes and vasopressor agents in critically ill patients.
@en
prefLabel
Use of inotropes and vasopressor agents in critically ill patients.
@ast
Use of inotropes and vasopressor agents in critically ill patients.
@en
P2860
P1476
Use of inotropes and vasopressor agents in critically ill patients
@en
P2093
Ming-Li Kong
P2860
P304
P356
10.1111/J.1476-5381.2011.01588.X
P407
P577
2012-04-01T00:00:00Z